Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
2,450 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Bajpai J, Pradhan A, Manek G, Maurya S, Kant S, Perrone MA. · Adv Respir Med · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Yoga effect on quality of life study among patients with idiopathic pulmonary fibrosis (YES-IPF).
Kadura S, Purkayastha S, Benditt J, Anand A, Collins B, De Quadros M, Hobson M, Biswas MJ, Ho L, Spino C, Raghu G. · Respir Med · 2026 · cited 2 timesrandomized controlled trial
- Phase 3 Antifibrotic-Directed Therapy Outcomes in Idiopathic Pulmonary Fibrosis: Beyond FVC Decline.
Kashizaki F, Watanabe S, Orii R, Lin H, Takeda J, Takagishi T, Osada R, Kaneko M, Yumoto K, Koizumi H. · Lung · 2026 · cited 0 timessystematic review
- Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
Nathan SD, Smith P, Deng C, De Salvo M, Wuyts W, Pavie-Gallegos J, Song JW, Kramer MR, King CS, Mackintosh JA, Chambers D, Miranda GV, Breytenbach N, Peterson L, Bell H, Flaherty KR, Behr J, Cottin V, TETON-2 Trial Investigators. · N Engl J Med · 2026 · cited 16 timesclinical trial, phase iii, multicenter study
- Effects of different durations of exercise-based pulmonary rehabilitation intervention in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Sun Y, Yuan J, Li M, Fan M, Li W, Zhang B, Li Y, Kang Z, Cheng H, Ren H, Chen M. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Comorbidities in clinical cohorts of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Leong MCH, Green S, Guan M, Walters TM, Marshall E, Sok C, Goh NSL, Ryerson CJ, Khor YH. · Eur Respir Rev · 2026 · cited 0 timesmeta-analysis, systematic review
- Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
Nathan SD, Smith P, Deng C, King CS, De Salvo M, Weigt SS, Pandya S, Bandyopadhyay D, Lasky JA, Krishna R, Hambly N, Ramaswamy M, Kebbe J, Ettinger N, Gao J, Rao Y, Breytenbach N, Peterson L, Bell H, Behr J, Cottin V, Flaherty KR, TETON-1 Trial Investigators. · N Engl J Med · 2026 · cited 9 timesclinical trial, phase iii, multicenter study
- Quality of life instruments in idiopathic pulmonary fibrosis: a COSMIN-based systematic review.
Zhang E, Gong J, Wang S, Duan Y, Ma S, Cheng H. · BMC Pulm Med · 2026 · cited 0 timesOpen accesssystematic review
- Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Kim K, Seok J, Yoon HY. · Pulmonology · 2026 · cited 0 timesmeta-analysis, systematic review
- Molecular Systems Architecture of Fibrotic Lung Microenvironment in Idiopathic Pulmonary Fibrosis.
Ayyadurai VAS, Manoharan Y, Deonikar P. · Cells · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.
Molyneaux PL, Hirani NA, Chia CCK, Kulkarni T, Zaman T, Kaner RJ, Coelho AL, Jannini-Sa YAP, Windsor B, Kruger S, Christensen DJ, Shoemaker SA, Hogaboam CM, MacKenzie B, Günther A. · Nat Commun · 2026 · cited 1 timesOpen accessresearch support, non-u.s. gov't, clinical trial, phase i
- Perioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta-Analysis.
Sanagawa A, Kato H, Fujimoto H, Kobayashi T, Iwamoto T. · Thorac Cancer · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Xu L, Zang D, Yan R, Liang Z, Yang S, Yu N, Yu X. · BMC Pulm Med · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Functional hyperpolarized gas magnetic resonance imaging of idiopathic pulmonary fibrosis: a systematic review.
Zaccagnini D, Magnini A, Cinci L, Calistri L, Cozzi D, Landini N, Miele V, Nardi C. · Radiol Med · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Prevalence of Gastroesophageal reflux disease in patients with Idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Li M, Yang J, Li H, Wang M. · BMC Pulm Med · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Design of the MERCURION-IPF trial - intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis.
Sotiropoulou V, Sampsonas F, Vasarmidi E, Antoniou K, Gogali A, Kostikas K, Drakopanagiotakis F, Steiropoulos P, Margaritopoulos G, Porpodis K, Daniil Z, Tomos I, Papanikolaou I, Tzilas V, Loukides S, Tzouvelekis A. · Front Immunol · 2026 · cited 0 timesOpen accessclinical trial, phase iii, methods-article
- Risk factors for idiopathic pulmonary fibrosis: an umbrella review of meta-analyses and mendelian randomization analyses.
Ruan H, Lei S, Wang J, Zhao H, Zhou X, Li J. · BMC Pulm Med · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Lung microbiome alterations in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis: A systematic review with insights into microbiome-host interactions and the gut-lung axis.
Dasgupta S, Roychowdhury S, Chaudhury K. · Respir Investig · 2026 · cited 0 timessystematic review, review
- Oral Nalbuphine in Idiopathic Pulmonary Fibrosis-Associated Cough: The CORAL Randomized Clinical Trial.
Molyneaux PL, Mogulkoc N, Gunen H, Doboszynska A, Kreuter M, Neustifter B, Mathur V, Cassella J, CORAL Study Group. · JAMA · 2026 · cited 8 timesclinical trial, phase ii, multicenter study
- Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial.
Maher TM, Hamblin MJ, Choi WI, Case AH, Tomos IP, Tzouvelekis AE, Shore JE, Bergna MA, Golod D, Elenko E, Zhang Y, Graham CS, Song JW, Kulkarni T, and the ELEVATE IPF Investigators. · Am J Respir Crit Care Med · 2026 · cited 4 timesOpen accessclinical trial, phase ii, comparative study
- Efficacy and Safety of Anticoagulants in Patients With Idiopathic Pulmonary Fibrosis: A Meta-Analysis.
Yang S, Xie D, Wang J, Yang Z, Xue X. · Can Respir J · 2025 · cited 1 timesOpen accessmeta-analysis, research support, non-u.s. gov't
- Comparative efficacy of different types of structured exercise interventions for idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Wang W, Gu Y, Mo L. · Front Med (Lausanne) · 2026 · cited 0 timessystematic review
- Interception of Regulatory RNAs on TGF-β Signaling in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Systematic Review.
Helal M, Kumar P, Rawat P, Magisetty J, Kondreddy V. · Curr Allergy Asthma Rep · 2026 · cited 1 timessystematic review
- Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use.
Diamantopoulos A, Pople O, Godman A, Papastergios E. · Pharmacoeconomics · 2026 · cited 0 timessystematic review
- Outcomes of patients with acute exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids: a systematic review and meta-analysis.
Mondoni M, Albrici C, Puci MV, Nalesso G, Cefalo J, Muresu N, Tirelli C, Belmonte LA, Ferranti G, Zava M, Sotgiu G. · Respir Res · 2026 · cited 4 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.